Episode 90 dives into quantum computing's emerging role in active pharmaceutical ingredient (API) manufacturing. Lucas and Luna explore a concrete example: how a collaboration between Roche and a quantum startup used a variational quantum eigensolver to optimize a synthesis pathway for a critical cancer drug, cutting solvent waste by 32% and reducing energy costs by 18% in pilot runs. They break down why classical molecular dynamics fails for catalytic reaction mechanisms, how quantum algorithms handle the electron correlation problem, and what this means for the $1.5 trillion pharmaceutical supply chain. The hosts also discuss the hardware limitations—current noisy qubits require hybrid classical-quantum workflows—and the timeline for industrial-scale adoption. Expect specific numbers, a clear explanation of quantum chemistry's advantage, and a grounded look at where the field stands in July 2026.

#QuantumComputing #DrugManufacturing #Pharmaceuticals #Roche #APIManufacturing #VariationalQuantumEigensolver #QuantumChemistry #CatalystOptimization #SustainablePharma #ProcessChemistry #HybridQuantumClassical #NoisyIntermediateScaleQuantum #SupplyChainOptimization #GreenChemistry #BusinessAndTechnology #FexingoBusiness #BusinessPodcast #LucasAndLuna

Keep every episode free: buymeacoffee.com/fexingo